Logo-aim
Arch Iran Med. 2022;25(7): 432-442.
doi: 10.34172/aim.2022.72
  Abstract View: 272
  PDF Download: 233

Original Article

The Role of CEP55 Expression in Tumor Immune Response and Prognosis of Patients with Non-small Cell lung Cancer

Haiyin Fan 1, Jin Zhang 2, Bin Zou 1, Zhisheng He 1* ORCID logo

1 Thoracic Department, Jiangxi Cancer Hospital, Nanchang, Jiangxi, China
2 Ultrasound Department, Jiangxi Chest Hospital, Nanchang, Jiangxi, China
*Corresponding Author: Corresponding Author: Zhisheng He, MD; 519 East Beijing Road, Nanchang, Jiangxi Province, Tel:+13 970935518, Email: , Email: hzs1973@sina.com

Abstract

Background: With the continuous advancement of diagnostic methods, more and more early-stage Non-small cell lung cancer (NSCLC) patients are diagnosed. Although many scholars have devoted substantial efforts to investigate the pathogenesis and prognosis of NSCLC, its molecular mechanism is still not well explained.

Methods: We retrieved three gene datasets GSE10072, GSE19188 and GSE40791 from the Gene Expression Omnibus (GEO) database and screened and identified differentially expressed genes (DEGs). Then, we performed KEGG and GO functional enrichment analysis, survival analysis, risk analysis and prognosis analysis on the selected hub genes. We constructed a protein-protein interaction (PPI) network, and used the STRING database and Cytoscape software.

Results: The biological process analysis showed that these genes were mainly enriched in cell division and nuclear division. Survival analysis showed that the genes of CEP55 (centrosomal protein 55), NMU (neuromedin U), CAV1 (Caveolin 1), TBX3 (T-box transcription factor 3), FBLN1 (fibulin 1) and SYNM (synemin) may be involved in the development, invasion or metastasis of NSCLC (P<0.05, logFC>1). Prognostic analysis and independent prognostic analysis showed that the expression of these hub gene-related mRNAs was related to the prognostic risk of NSCLC. Risk analysis showed that the selected hub genes were closely related to the overall survival time of patients with NSCLC.

Conclusion: The DEGs and hub genes screened and identified in this study will help us to understand the molecular mechanisms of NSCLC, and CEP55 expression affects the survival and prognosis of patients with NSCLC, and participates in tumor immune response.


Cite this article as: Fan H, Zhang J, Zou B, He Z. The role of cep55 expression in tumor immune response and prognosis of patients with non-small cell lung cancer. Arch Iran Med. 2022;25(7):432-442. doi: 10.34172/aim.2022.72
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 273

Your browser does not support the canvas element.


PDF Download: 233

Your browser does not support the canvas element.

Submitted: 24 Apr 2021
Revision: 03 Nov 2021
Accepted: 20 Nov 2021
ePublished: 01 Jul 2022
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)